France · Delayed Price · Currency is EUR Vetoquinol Statistics
Total Valuation
Vetoquinol has a market cap or net worth of EUR 855.38 million. The enterprise value is 632.60 million.
| Market Cap | 855.38M |
| Enterprise Value | 632.60M |
Important Dates
The last earnings date was Friday, September 11, 2026.
| Earnings Date | Sep 11, 2026 |
| Ex-Dividend Date | Jun 3, 2026 |
Share Statistics
Vetoquinol has 11.62 million shares outstanding. The number of shares has decreased by -1.94% in one year.
| Current Share Class | 11.62M |
| Shares Outstanding | 11.62M |
| Shares Change (YoY) | -1.94% |
| Shares Change (QoQ) | +1.09% |
| Owned by Insiders (%) | 4.01% |
| Owned by Institutions (%) | 8.61% |
| Float | 3.66M |
Valuation Ratios
The trailing PE ratio is 13.51 and the forward PE ratio is 13.41.
| PE Ratio | 13.51 |
| Forward PE | 13.41 |
| PS Ratio | 1.62 |
| PB Ratio | 1.41 |
| P/TBV Ratio | 2.08 |
| P/FCF Ratio | 10.23 |
| P/OCF Ratio | 8.70 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.58, with an EV/FCF ratio of 7.56.
| EV / Earnings | 10.07 |
| EV / Sales | 1.20 |
| EV / EBITDA | 5.58 |
| EV / EBIT | 7.51 |
| EV / FCF | 7.56 |
Financial Position
The company has a current ratio of 3.35, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.35 |
| Quick Ratio | 2.36 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | 0.15 |
| Interest Coverage | 62.74 |
Financial Efficiency
Return on equity (ROE) is 10.68% and return on invested capital (ROIC) is 15.67%.
| Return on Equity (ROE) | 10.68% |
| Return on Assets (ROA) | 7.04% |
| Return on Invested Capital (ROIC) | 15.67% |
| Return on Capital Employed (ROCE) | 13.37% |
| Weighted Average Cost of Capital (WACC) | 9.04% |
| Revenue Per Employee | 208,766 |
| Profits Per Employee | 24,874 |
| Employee Count | 2,526 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 1.64 |
Taxes
In the past 12 months, Vetoquinol has paid 24.69 million in taxes.
| Income Tax | 24.69M |
| Effective Tax Rate | 28.21% |
Stock Price Statistics
The stock price has decreased by -6.12% in the last 52 weeks. The beta is 0.87, so Vetoquinol's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | -6.12% |
| 50-Day Moving Average | 72.23 |
| 200-Day Moving Average | 76.73 |
| Relative Strength Index (RSI) | 50.19 |
| Average Volume (20 Days) | 9,414 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vetoquinol had revenue of EUR 527.34 million and earned 62.83 million in profits. Earnings per share was 5.45.
| Revenue | 527.34M |
| Gross Profit | 311.69M |
| Operating Income | 84.26M |
| Pretax Income | 87.50M |
| Net Income | 62.83M |
| EBITDA | 107.26M |
| EBIT | 84.26M |
| Earnings Per Share (EPS) | 5.45 |
Balance Sheet
The company has 235.20 million in cash and 12.35 million in debt, with a net cash position of 222.85 million or 19.17 per share.
| Cash & Cash Equivalents | 235.20M |
| Total Debt | 12.35M |
| Net Cash | 222.85M |
| Net Cash Per Share | 19.17 |
| Equity (Book Value) | 608.80M |
| Book Value Per Share | 52.48 |
| Working Capital | 330.19M |
Cash Flow
In the last 12 months, operating cash flow was 98.34 million and capital expenditures -14.69 million, giving a free cash flow of 83.65 million.
| Operating Cash Flow | 98.34M |
| Capital Expenditures | -14.69M |
| Depreciation & Amortization | 23.00M |
| Net Borrowing | -1.26M |
| Free Cash Flow | 83.65M |
| FCF Per Share | 7.20 |
Margins
Gross margin is 59.11%, with operating and profit margins of 15.98% and 11.91%.
| Gross Margin | 59.11% |
| Operating Margin | 15.98% |
| Pretax Margin | 16.59% |
| Profit Margin | 11.91% |
| EBITDA Margin | 20.34% |
| EBIT Margin | 15.98% |
| FCF Margin | 15.86% |
Dividends & Yields
This stock pays an annual dividend of 0.93, which amounts to a dividend yield of 1.26%.
| Dividend Per Share | 0.93 |
| Dividend Yield | 1.26% |
| Dividend Growth (YoY) | 4.49% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 17.59% |
| FCF Payout Ratio | 12.92% |
| Buyback Yield | 1.94% |
| Shareholder Yield | 3.20% |
| Earnings Yield | 7.35% |
| FCF Yield | 9.78% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Vetoquinol is 91.50, which is 24.32% higher than the current price. The consensus rating is "Buy".
| Price Target | 91.50 |
| Price Target Difference | 24.32% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 2.92% |
| EPS Growth Forecast (3Y) | 6.90% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Vetoquinol has an Altman Z-Score of 5 and a Piotroski F-Score of 7.
| Altman Z-Score | 5 |
| Piotroski F-Score | 7 |